- Published at
- by seekingalpha.com
neutral
neutral
Reata Pharmaceuticals, Inc. (RETA) CEO Warren Huff on Q4 2020 Results - Earnings Call Transcript
Reata Pharmaceuticals, Inc. (NASDAQ:RETA) Q4 2020 Earnings Conference Call March 01, 2021 08:30 A.M.
News for Reata Pharmaceuticals, Inc. (2R3.F)
- Published at
- by seekingalpha.com
neutralneutralReata Pharmaceuticals, Inc. 2020 Q4 - Results - Earnings Call Presentation (NASDAQ:RETA)
The following slide deck was published by Reata Pharmaceuticals, Inc.- Published at
- by sec.gov
positivepositiveEDGAR Filing Documents for 0001564590-21-009624
Mailing Address 5320 LEGACY DRIVE PLANO TX 75024 Business Address 5320 LEGACY DRIVE PLANO TX 75024 972-865-2219 CIK : 0001358762 (see all company filings) REA...- Published at
- by benzinga.com
mixedmixedThe Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings
Biotech stocks extended their losses in the week ended Feb. 26 amid continued weakness in the broader market. Earnings came in thick and fast, with a skew ...SRPTPFED.BAPFE.SGPFE.MXPFE.MUPFE.FPFE.DEPFE.BEPFEMRNA.MXMRNAGIS.MUGIS.FGIS.DEGIS.BEGILD.MXGILD.MIGILDBNTXN.MXBNTXAQSTAB3A.SGAB3A.MUAB3A.FAB3A.BE22UA.MU22UA.F22UA.DE22UA.BE0QF.SG0QF.MU0QF.F0QF.BEXP0.SGXP0.FXFORXENEVORTXMDTTOOTPTXTERNSYRSSYNSTIMSNSESILKSFYC.FSFYC.BESBBPSANARIGLRI2A.MURI2A.FRI2A.BERGNXRETARB0.MURB0.FRB0.BEPHVSPGENPASGPANDOSUROPTNOPNTOMERNVV1.MUNVV1.FNVV1.BENVAX.MXNVAXNRC.SGNRC.MUNRC.FMRK.PAMRK.MXMRKMJC.MUMJC.FMCRBLHDXLABPINO.MXINOINMBI9DN.SGI9DN.MUI9DN.FI9DN.BEI5X.FGLYCGKO.FGKO.BEGBMB.SGGBMB.MUGBMB.FGBMB.BEFOLD.MXFOLDFLGT.MXFLGTFGENFBIOEYPTEVFMEVAXEP3.SGEP3.FEGRXDMTK.MXDMTKCXS.SGCXS.FCXS.BECNB.FCNB.BECLPTCHMACCXIBOLTBHVNAXSMAVU.FAVU.BEATXIATRSATRAATNXAT2.FAT2.BEANIKANGNAM6.FAM6.BEAKP.FAKP.BEAGRXADVMADAGACORABUS7F0.F7F0.BE6MK.MU6MK.F6MK.DE6MK.BE69BN.SG69BN.F49Y.F49Y.BE48Q.F3T2.MU3T2.F3T2.BE3O8.MU3O8.F3O8.BE2R3.F2OW.MU2OW.F2OW.BE2MT.F2CX.SG2CX.MU2CX.BE29T.F29T.BE1S9.SG1S9.F1S9.BE1FG.F1E6.SG1E6.F1AQ1.MU1AQ1.F1AQ1.BE19X.SG19X.MU19X.F19X.BE0S9.F0OP.F0OP.BE0AL.F0AL.BESPPINTR.BE- Published at
- by yahoo.com
mixedmixedCNS Pharmaceuticals Berubicin Trial is On Schedule to Commence in March 2021
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) (- Published at
- by benzinga.com
mixedmixedWPD Pharmaceuticals Announces Berubicin Supply Agreement for the Upcoming Clinical Trials
VANCOUVER, British Columbia, Feb. 24, 2021 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals (CSE:WBIO) (8SV1.F) ("WPD" or the "Company") today announced that ...- Published at
- by markets.businessinsider.com
positivepositiveWPD and CNS Pharmaceuticals Announce Positive Opinion of the Polish Central Ethics Committee for the WPD-201 Study and Central IRB Study Level Approval for the CNS-201 Study
WPD Pharmaceuticals plans to initiate a Berubicin Phase 2 adult GBM trial in the first half of 2021 and a multicenter pediatric malignant glioma P...- Published at
- by sec.gov
positivepositiveEDGAR Filing Documents for 0001564590-21-000742
Mailing Address 5320 LEGACY DRIVE PLANO TX 75024 Business Address 5320 LEGACY DRIVE PLANO TX 75024 972-865-2219 CIK : 0001358762 (see all company filings) REA...